share_log

百奥泰 自愿披露关于BAT8008联合贝伐珠单抗或联合BAT7104获得药物临床试验批准通知书的公告

Biotech voluntarily disclosed the announcement that BAT8008 combined with bevacizumab or combined BAT7104 obtained a notice of approval for drug clinical trials

SZSI ·  May 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more